ARDT

ARDT

USD

Ardent Health Partners Inc. Common Stock

$13.170+0.440 (3.456%)

Цена в режиме реального времени

Healthcare
Medical Care Facilities
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$12.730

Максимум

$13.300

Минимум

$12.650

Объем

0.05M

Фундаментальные показатели компании

Рыночная капитализация

1.9B

Отрасль

Medical Care Facilities

Страна

United States

Статистические данные торговли

Средний объем

0.45M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $11.31Текущая $13.170Максимум $20.72

Отчет об анализе ИИ

Последнее обновление: 28 апр. 2025 г.
Сгенерировано ИИИсточник данных: Yahoo Finance, Bloomberg, SEC

ARDT: Ardent Health Partners Inc. Common Stock - What's Happening and What to Watch

Stock Symbol: ARDT Generate Date: 2025-04-28 13:38:57

Let's break down what's been going on with Ardent Health Partners, looking at the recent news, how the stock price has moved, and what some predictions are saying. Ardent Health, remember, runs hospitals and clinics in mid-sized cities across the U.S., offering all sorts of medical services.

Recent News Buzz

The news flow for ARDT lately seems pretty positive overall.

First off, the company announced when they'll share their first quarter 2025 financial results – that's coming up after the market closes on Tuesday, April 29th. This is a big one; everyone will be watching to see how the business is actually performing.

We also saw some analyst activity earlier in April. Guggenheim started covering the stock with a "Buy" rating and put a $16 price target on it. That's a vote of confidence from a new analyst. Around the same time, Mizuho kept their "Outperform" rating, which is also positive, though they slightly lowered their price target from $19 to $18. Still, both targets are well above where the stock is trading right now.

Adding to the positive feel, Ardent Health also appointed a new member, Robert DeMichiei, to their board of directors. Bringing in seasoned leadership is often seen as a good sign for a company's governance and future direction.

So, the general vibe from the news is leaning positive, with analysts seeing potential and the company making moves like strengthening its board and preparing to report earnings.

Checking the Price Action

Looking at the stock's movement over the last few months tells an interesting story. Back in late January and early February, the price was hanging out mostly between $14.50 and $15.50. Things got a bit choppy in late February and March, with some bigger swings and higher volume days.

However, since early April, the trend has been noticeably downward. The price dropped from around $13.50 at the start of April to the $11-$12 range. The last recorded price is $12.53. This recent dip contrasts with the generally positive news sentiment we just talked about.

The AI prediction model suggests this recent slide might be turning around, at least in the very short term. It predicts the price will increase by about 1.75% today, 2.77% tomorrow, and 3.89% the day after. These are small but consistent predicted upward moves.

Putting It Together: Outlook & Ideas

Based on the mix of information – positive analyst ratings and board news, an upcoming earnings report, a recent price decline, and AI predicting a short-term bounce – the apparent near-term leaning seems cautiously optimistic, especially if the AI prediction holds true.

Why cautiously optimistic? You have analysts who think the stock should be trading significantly higher ($16-$18 targets), and the AI sees upward movement right now. The upcoming earnings report is the big unknown; good results could validate the analyst views and potentially reverse the recent price trend. Bad results, of course, could send it lower.

Given the recent price dip and the AI's prediction of upward movement starting now, a potential entry consideration might be around the current price level ($12.53) or perhaps on any slight dip back towards the recent lows around $11.31 (which also happens to be the 52-week low). The idea here is potentially buying low relative to recent history and analyst targets, aligning with the AI's short-term forecast.

For managing risk, a potential stop-loss consideration could be set just below the recent 52-week low of $11.31. If the price falls below that level, it could signal that the recent downturn is continuing despite the positive news and predictions.

On the upside, if the stock does start moving up as the AI suggests and the earnings report is positive, potential take-profit levels could be considered as it approaches the analyst targets, perhaps starting around the lower target of $16 or even higher towards $18 if momentum builds.

Company Context

It's worth remembering that Ardent Health is in the Medical Care Facilities industry within the broader Healthcare sector. This means its performance can be influenced by healthcare policy changes, patient volumes, insurance dynamics, and the general health of the economy affecting people's ability to seek care. The upcoming earnings report will give a clearer picture of how these factors are currently impacting their business operations and finances.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Связанные новости

BusinessWire

Seven Ardent Health Facilities Earn "A" Hospital Safety Grade from The Leapfrog Group

Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that seven of its facilities earned an "A" Hospital Safety Grade from The Leapfrog

Просмотреть больше
Seven Ardent Health Facilities Earn "A" Hospital Safety Grade from The Leapfrog Group
BusinessWire

Ardent Health Announces First Quarter 2025 Results Conference Call and Webcast Date

Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its first quarter 2025 results after the market closes on Tuesday,

Просмотреть больше
Ardent Health Announces First Quarter 2025 Results Conference Call and Webcast Date

Прогноз ИИBeta

Рекомендация ИИ

Бычий

Обновлено в: 3 мая 2025 г., 11:01

МедвежийНейтральныйБычий

69.1% Уверенность

Риск и торговля

Уровень риска3/5
Средний риск
Подходит для
Стоимость
Руководство по торговле

Точка входа

$13.20

Взять прибыль

$13.43

Остановить убытки

$11.85

Ключевые факторы

PDI 10.3 выше MDI 10.2 с ADX 24.9, что предполагает бычий тренд
Текущая цена очень близка к уровню поддержки ($13.18), что предполагает сильную возможность покупки
Объем торгов в 7.1 раз превышает среднее значение (4,135), что указывает на чрезвычайно сильное покупательское давление
MACD 0.0313 ниже сигнальной линии 0.0369, что указывает на медвежье пересечение

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.